Alimta (pemetrexed), from Eli Lilly & Co. is first drug to be approved by FDA for treatment of mesothelioma who are not candidates for resection or curative surgery
FDA Approves Sulopenem Etzadroxil and Probenecid for Uncomplicated UTIs
The FDA has approved just the second treatment for uncomplicated urinary tract infections (UTIs) in the last 2 decades.
Keeping the Focus on Community Pharmacy Advocacy at the State Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Q&A: Health Care Experts on H5 Bird Flu Vaccine Developments
As the H5 bird flu outbreak gradually impacts human health in the US, health care experts weighed in on possibilities of a future vaccine.
How Pharmacy Advocacy is Heating Up at the Federal Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
GLP-1, SGLT2 Prescriptions for Patients With T1D Increased Over Past Decade
A recent study found the percentage of type 1 diabetes patients who were prescribed either GLP-1s or SGLT2 inhibitors increased from 0.7% to 8.3% between 2010 and 2023.
ACIP Votes to Lower Recommended Age of Pneumococcal Vaccination
The new recommendations suggest vaccination at age 50, rather than age 65.